Nishan Abeysuriya

Nishan Abeysuriya

Auto-generated profile, based on publicly available information

Nishan Abeysuriya

University of Queensland, Brisbane, Queensland, Australia

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 October 2018 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
NWNelson Wang
Nelson Wang
JFJordan Fulcher
Jordan Fulcher
NANishan Abeysuriya
Nishan Abeysuriya
MMMichele McGrady
Michele McGrady
IWIan Wilcox
Ian Wilcox
SLSean Lal
Sean Lal
To undertake a systematic review and meta-analysis to determine the influence of tricuspid regurgitation (TR) severity on mortality. We performed a systematic search for studies reporting clinical outcomes of patients with TR. The primary endpoint was all-cause mortality and secondary endpoints were cardiac mortality and hospitalization for heart failure (HF). Overall risk ratios (RR) and 95% confidence intervals (CIs) were derived for each endpoint according to the severity of TR by meta-analysing the effect estimates of eligible studies. Seventy studies totalling 32 601 patients were included in the analysis, with a mean (±SD) follow-up of 3.2 ± 2.1 years. Moderate/severe TR was associated with a two-fold increased mortality risk compared to no/mild TR (RR 1.95, 95% CI 1.75–2.17). Moderate/severe TR remained associated with higher all-cause mortality among 13 studies which adjusted for systolic pulmonary arterial pressures (RR 1.85, 95% CI 1.44–2.39), and 15 studies, which adjusted for right ventricular (RV) dysfunction (RR 1.78, 95% CI 1.49–2.13). Moderate/severe TR was also associated with increased cardiac mortality (RR 2.56, 95% CI 1.84–3.55) and HF hospitalization (RR 1.73, 95% CI 1.14–2.62). Compared to patients with no TR, patients with mild, moderate, and severe TR had a progressively increased risk of all-cause mortality (RR 1.25, 1.61, and 3.44, respectively; P < 0.001 for trend). Moderate/severe TR is associated with an increased mortality risk, which appears to be independent of pulmonary pressures and RV dysfunction.

6 October 2017 in Heart
Verified
Journal Article
Closed access
PDF file
NWNelson Wang
Nelson Wang
JFJordan Fulcher
Jordan Fulcher
NANishan Abeysuriya
Nishan Abeysuriya
MAMark Adams
Mark Adams
SLSean Lal
Sean Lal
Objective The aim of this study was to identify positive and negative predictors of technical and clinical success for percutaneous coronary intervention (PCI) of chronic total occlusions (CTO). Methods We conducted a systematic review and meta-analysis of studies published between 2000 and 2016 analysing rates of CTO PCI success with respect to demographic and angiographic characteristics. Crude ORs and 95% CIs for each predictor were calculated using a random effects model. Predictors of technical and clinical success were assessed among 28 demographic and 31 angiographic variables. Clinical success was defined as technical success without major adverse cardiac events. Results A total of 61 studies, totalling 69 886 patients were included in this analysis. The major demographic characteristics associated with a 20% or greater reduction in the odds of technical and clinical success were a history of myocardial infarction, PCI, coronary artery bypass grafting, stroke/transient ischaemic attack and peripheral vascular disease. Angiographic factors were generally stronger predictors of reduced technical and clinical success. Those associated with >20% odds reduction included non-left anterior descending CTOs, multivessel disease, presence of bridging collaterals, moderate-to-severe calcification, >45 degree vessel bending, tortuous vessel, blunt stump and ostial lesions. Of these, novel predictors included prior PCI, prior stroke, peripheral vascular disease, presence of multivessel disease and bridging collaterals. Conclusion The present study has identified strong negative predictors for clinical success for CTO PCI, which will aid in patient selection for this procedure.